Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Ophthalmological Medicine
Volume 2015, Article ID 516921, 3 pages
http://dx.doi.org/10.1155/2015/516921
Case Report

Fellow Eye Macular Edema Improvement after Intravitreal Bevacizumab for Radiation Retinopathy

University of São Paulo, Rua Marieta Alves 116, 041815-260 Salvador, BA, Brazil

Received 15 June 2015; Revised 28 September 2015; Accepted 29 September 2015

Academic Editor: Maurizio Battaglia Parodi

Copyright © 2015 Isis A. S. Brito et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. T. Finger, K. J. Chin, G. Duvall, and The Palladium-103 for Choroidal Melanoma Study Group, “Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients,” Ophthalmology, vol. 116, no. 4, pp. 790.e1–796.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Krema, S. Somani, A. Sahgal et al., “Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up,” British Journal of Ophthalmology, vol. 93, no. 9, pp. 1172–1176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. S. Gragoudas, J. M. Seddon, K. Egan et al., “Long-term results of proton beam irradiated uveal melanomas,” Ophthalmology, vol. 94, no. 4, pp. 349–353, 1987. View at Publisher · View at Google Scholar
  4. G. C. Brown, J. A. Shields, G. Sanborn, J. J. Augsburger, P. J. Savino, and N. J. Schatz, “Radiation retinopathy,” Ophthalmology, vol. 89, no. 12, pp. 1494–1501, 1982. View at Publisher · View at Google Scholar · View at Scopus
  5. D. C. Chacko, “Considerations in the diagnosis of radiation injury,” The Journal of the American Medical Association, vol. 245, no. 12, pp. 1255–1258, 1981. View at Publisher · View at Google Scholar · View at Scopus
  6. W. M. K. Amoaku and D. B. Archer, “Cephalic radiation and retinal vasculopathy,” Eye, vol. 4, no. 1, pp. 195–203, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Kinyoun, “Long-term visual acuity results of treated and untreated radiation retinopathy (An AOS thesis),” Transactions of the American Ophthalmological Society, vol. 106, pp. 325–335, 2008. View at Google Scholar · View at Scopus
  8. N. V. Shah, S. K. Houston, A. Markoe, and T. G. Murray, “Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma,” Clinical Ophthalmology, vol. 7, pp. 1877–1882, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. J. Bakri and T. A. Larson, “The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy,” Seminars in Ophthalmology, vol. 30, no. 4, pp. 276–280, 2015. View at Publisher · View at Google Scholar
  10. N. Horgan, C. L. Shields, A. Mashayekhi et al., “Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma,” Retina, vol. 28, no. 7, pp. 987–995, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. O. Mason III, M. A. Albert Jr., T. O. Persaud, and R. S. Vail, “Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma,” Retina, vol. 27, no. 7, pp. 903–907, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Gupta and J. S. Muecke, “Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin),” Retina, vol. 28, no. 7, pp. 964–968, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. P. T. Finger and K. Chin, “Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy,” Archives of Ophthalmology, vol. 125, no. 6, pp. 751–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. P. T. Finger, “Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin),” International Journal of Radiation Oncology Biology Physics, vol. 70, no. 4, pp. 974–977, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Solano, S. J. Bakri, and J. S. Pulido, “Regression of radiation-induced macular edema after systemic bevacizumab,” Canadian Journal of Ophthalmology, vol. 42, no. 5, pp. 748–749, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Dunavoelgyi, M. Zehetmayer, C. Simader, and U. Schmidt-Erfurth, “Rapid improvement of radiation-induced neovascular glaucoma and exudative retinal detachment after a single intravitreal ranibizumab injection,” Clinical and Experimental Ophthalmology, vol. 35, no. 9, pp. 878–880, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. P. T. Finger and K. J. Chin, “Intravitreous ranibizumab (lucentis) for radiation maculopathy,” Archives of Ophthalmology, vol. 128, no. 2, pp. 249–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. G. P. Giuliari, A. Sadaka, D. M. Hinkle, and E. R. Simpson, “Current treatments for radiation retinopathy,” Acta Oncologica, vol. 50, no. 1, pp. 6–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. B. Archer, W. M. K. Amoaku, and T. A. Gardiner, “Radiation retinopathy-clinical, histopathological, ultrastructural and experimental correlations,” Eye, vol. 5, no. 2, pp. 239–251, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. Irvine, J. A. Alvarado, W. M. Wara, B. W. Morris, and I. S. Wood, “Radiation retinopathy: an experimental model for the ischemic—proliferative retinopathies,” Transactions of the American Ophthalmological Society, vol. 79, pp. 103–122, 1981. View at Google Scholar · View at Scopus
  21. E. Midena, T. Segato, M. Valenti, C. D. Angeli, E. Bertoja, and S. Piermarocchi, “The effect of external eye irradiation on choroidal circulation,” Ophthalmology, vol. 103, no. 10, pp. 1651–1660, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Horgan, C. L. Shields, A. Mashayekhi, L. F. Teixeira, M. A. Materin, and J. A. Shields, “Early macular morphological changes following plaque radiotherapy for uveal melanoma,” Retina, vol. 28, no. 2, pp. 263–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Horgan, C. L. Shields, A. Mashayekhi, and J. A. Shields, “Classification and treatment of radiation maculopathy,” Current Opinion in Ophthalmology, vol. 21, no. 3, pp. 233–238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Matsuyama, N. Ogata, M. Matsuoka, M. Wada, T. Nishimura, and K. Takahashi, “Effects of intravitreally injected bevacizumab on vascular endothelial growth factor in fellow eyes,” Journal of Ocular Pharmacology and Therapeutics, vol. 27, no. 4, pp. 379–383, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Semeraro, F. Morescalchi, S. Duse, E. Gambicorti, M. R. Romano, and C. Costagliola, “Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview,” Expert Opinion on Drug Safety, vol. 13, no. 6, pp. 785–802, 2014. View at Publisher · View at Google Scholar · View at Scopus